Skip Navigation


Annals of Oncology Advance Access originally published online on September 13, 2009
Annals of Oncology 2009 20(11):1896-1897; doi:10.1093/annonc/mdp413
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
20/11/1896    most recent
mdp413v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by de la Haba Rodríguez, J. R.
Right arrow Articles by Aranda, E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by de la Haba Rodríguez, J. R.
Right arrow Articles by Aranda, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

letters to the editor

Fulvestrant in advanced male breast cancer

The first 10% of the full text of this article appears below.

case report

A 64-year-old man was diagnosed with breast cancer and underwent surgery in October 2000, when a radical mastectomy and axillary node dissection were carried out. Pathological examination revealed a 3 x 2 cm2 well-differentiated, invasive, ductal breast carcinoma (stage IIb), involving 1 of the 12 nodes that were tested. The tumour was found to be positive for both estrogen receptor (ER present in 40% of the tumoral cells) and progesterone receptor (in the 90% . . . [Full Text of this Article]

discussion

J. R. de la Haba Rodríguez*, I. Porras Quintela, G. Pulido Cortijo, M. Berciano Guerrero and E. Aranda

Department of Medical Oncology, Hospital Universitario Reina Sofia, Cordoba, Spain

* (E-mail: juandelahaba@hotmail.com)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?